SCHEMBL2125191

SCHEMBL2125191

C=C(C)C(=O)Oc1ccc2c(c1)C(C)c1cc(OC(=O)C(=C)C)ccc1-2

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ELANE P08246 1/20 0.46
KMT2A Q03164 2/20 0.43
ATM Q13315 1/20 0.43
POLB P06746 2/20 0.35
APEX1 P27695 1/20 0.35
HTT P42858 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
MAPT P10636 1/20 0.34
HTR7 P34969 1/20 0.34
HTR2B P41595 1/20 0.34
OPRM1 P35372 1/20 0.33
KDM4E B2RXH2 1/20 0.32
ALDH1A1 P00352 1/20 0.31
ACHE P22303 3/20 0.31
BACE1 P56817 1/20 0.31
LMNA P02545 2/20 0.31
CYP3A4 P08684 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2604688 0.89 ELANE (0.39) ELANEKMT2AATMPOLBAPEX1
SCHEMBL21266419 0.87 ELANE (0.46) ELANEKMT2AATMPOLBAPEX1
SCHEMBL2604686 0.86 HTR7 (0.33) ELANEKMT2AATMHTR7HTR2B
SCHEMBL23082664 0.84 ELANE (0.40) ELANEKMT2AATMPOLBAPEX1
SCHEMBL2604672 0.83 ELANE (0.43) ELANEKMT2AATMPOLBAPEX1
SCHEMBL22099322 0.83 ELANE (0.42) ELANEKMT2AATMPOLBAPEX1
SCHEMBL22099383 0.83 ELANE (0.42) ELANEKMT2AATMPOLBAPEX1
SCHEMBL6536369 0.83 LMNA (0.47) ELANEKMT2APOLBTDP1MAPT
SCHEMBL21266330 0.82 ELANE (0.41) ELANEKMT2AATMPOLBAPEX1
SCHEMBL21266144 0.82 ELANE (0.41) ELANEKMT2AATMPOLBAPEX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8394468-B2 Polymerizable compound and liquid crystal composition including it JNC CORPORATION (JP) 2013-03-12 US disclosed
US-8394468-B2 Polymerizable compound and liquid crystal composition including it JNC CORPORATION (JP) 2013-03-12 US disclosed
US-8394468-B2 Polymerizable compound and liquid crystal composition including it JNC CORPORATION (JP) 2013-03-12 US disclosed
US-20120092608-A1 POLYMERIZABLE COMPOUND AND LIQUID CRYSTAL COMPOSITION INCLUDING IT JNC PETROCHEMICAL CORPORATION (JP) 2012-04-19 US disclosed
US-20120092608-A1 POLYMERIZABLE COMPOUND AND LIQUID CRYSTAL COMPOSITION INCLUDING IT JNC PETROCHEMICAL CORPORATION (JP) 2012-04-19 US disclosed
US-20120092608-A1 POLYMERIZABLE COMPOUND AND LIQUID CRYSTAL COMPOSITION INCLUDING IT JNC PETROCHEMICAL CORPORATION (JP) 2012-04-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120092608-A1 POLYMERIZABLE COMPOUND AND LIQUID CRYSTAL COMPOSITION INCLUDING IT KLK3, PDE7A, FZD7 ELANE 2411/4885KMT2A 3313/4885ATM 737/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.